Jefferies Adjusts Price Target on Eli Lilly to $1,020 From $996
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
Pre-market 07:41:31 am | |||
842.18 USD | +1.95% |
|
850.83 | +1.03% |
07:33am | Palatin Completes Phase 2 Obesity Study With Mc4r Bremelanotide Plus Glp-1/Gip Tirzepatide | RE |
07:27am | Futures subdued as investors assess big corporate results | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration